Animal gene-editing researchers leaving US to escape FDA’s ‘regulatory confusion’

cows
Gene-edited animals face uncertain future under proposed FDA regulations

In a few weeks, reproductive biologist Charles Long will travel from Texas to São Paulo, Brazil in search of collaborators willing to take on his studies of gene-edited cattle. He is reluctant to ship the project away from his laboratory at Texas A&M University in College Station. But after 20 years of struggling to win US government funding for his research, Long says that he is done.

“We’ve essentially given up,” he says. “I’m going to move the entire damn project down there.”

US researchers who develop genetically engineered livestock have long dealt with….an uncertain path to market. Many had hoped that the advent of genome-editing technologies….would mean less oversight by the….FDA….

But in 2017, the FDA released draft guidance that suggested it will regulate gene-edited animals, too, as ‘animal drugs’. The only animal that the FDA has approved via that pathway is a fast-growing genetically engineered salmon, in a decision that was decades in the making….

…

That leaves US researchers in a bind. Federal funding for genetically engineered or edited livestock is in short supply. Geneticist Kevin Wells of the University of Missouri in Columbia can recall only one such grant in the last 30 years. Researchers have leaned on industry funding to pick up the slack — but this, too, might run dry if companies can’t bring their animals to market.

Read full, original article: Gene-edited animal creators look beyond US market

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-10-07-at-1.03.15-PM
Anti-vaxxers’ double whammy: Exaggerated vaccine fears have fueled measles outbreaks and preventable deaths—and left survivors more vulnerable to other infections for years
Crossed-Out-Calendar-with-Milk-Carton
Viewpoint: The shocking consequences after a year of Robert F. Kennedy Jr.'s distortions, deceptions, and flat-out falsehoods
Frosted Blueberries Under Magnification
MAHA moms divided over RFK Jr.’s food‑safety efforts, as recall alerts grow and outbreaks spread
Pride and Patriotism in the Breeze
Retreat from identity labels: Does the sharply declining number of young teens identifying as gay and bisexual reflect an ideological shift?
Screenshot-2026-10-08-at-10.41.33-AM
Viewpoint: Wellness patches: Most vitamin supplements are useless and sometimes even dangerous, but this craze is even worse
Screenshot-2026-10-13-at-10.35.49-AM
Challenging health misinformation? People are more likely to believe AI when it responds with empathy
Golden Wheat Under a Starry Sky
Viewpoint: ‘Bureaucratic and economic obstacles’ to agricultural biotechnology: Europe creeps into the 21st century, but blocks remain
Screenshot-2026-10-12-at-10.44.38-AM
Widely condemned as unethical, hepatitis B vaccine study funded by RFK Jr’s CDC gets a final greenlight
Prescription Capsules Scattered on Twenty-Dollar Bills
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it, Part 2
Cross and Syringe Standoff
Viewpoint: Hijacking Jesus: How anti-vaccine fanatics are exploiting religious exemptions and killing children
Executive-Greeting-in-a-Futuristic-Boardroom
Viewpoint: RFK Jr. touts AI to guide health care…but searches using the technology he champions expose him as scientifically illiterate
Screenshot-2026-09-22-at-12.26.15-PM
‘Forever chemical’ concerns: Separating hysteria from reasonable concern in the debate over PFAS danger
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.